GENTEX CORP (GNTX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000355811 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 24, 2026 | $651.3M | $114.7M | $0.54 | Filing |
| Mar 31, 2026 | Apr 24, 2026 | $675.4M | $98.5M | $0.46 | Filing |
| Dec 31, 2025 | Jan 30, 2026 | $644.4M | $93.0M | $0.43 | Filing |
| Sep 30, 2025 | Oct 24, 2025 | $655.2M | $101.0M | $0.46 | Filing |
| Jun 30, 2025 | Jul 25, 2025 | $657.9M | $96.0M | $0.43 | Filing |
| Mar 31, 2025 | Apr 25, 2025 | $576.8M | $94.9M | $0.42 | Filing |
| Dec 31, 2024 | Jan 31, 2025 | $541.6M | $87.7M | $0.39 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $608.5M | $122.5M | $0.53 | Filing |
What would GENTEX CORP have to report for its valuation to change?
At $21.01, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -1.0% a year, to $1.80. On that path the next quarter needs diluted EPS near $0.46, against $0.46 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -1.0% | -1.0% |
| EPS needed in final year | $1.80 | $1.80 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. GNTX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.